IV InterAmerican Oncology Conference

IV InterAmerican Oncology Conference

Fecha de Inicio: 6 de Octubre de 2011

Fecha de Finalización: 7 de Octubre de 2011

Sede: Alvear Palace Hotel, Salón Versailles, CABA, Argentina.

• Autoridades

Román Perez Soler, M.D., Albert Einstein College of Medicine, New York, USA
Carlos L. Arteaga, M.D., Vanderbilt University School of Medicine, Nashville, USA

• Comité organizador

- Román Perez Soler, New York, USA
- Carlos L. Arteaga, Nashville, USA
- Andrea Blanco, Buenos Aires, Argentina

• Comité científico
 
- Alex Adjei, M.D., Roswell Park Cancer Institute, Buffalo, NY, USA
- Kenneth C. Anderson, M.D., Dana-Farber Cancer Institute Boston, USA
- Carlos L. Arteaga, M.D., Vanderbilt University School of Medicine, Nashville, USA
- Hernan Cortes Funes, M.D., Hospital Universitario "12 de Octubre", Madrid, Spain
- Edith Perez,M.D., Mayo Clinic, Jacksonville, Florida, USA
- Roman Perez Soler, M.D., Albert Einstein College of Medicine, Bronx, NY, USA

• Disertantes
 
- Alex A. Adjei, M.D., Ph.D.
Professor and Chair, Department of Medicine
Katherine Anne Gioia Chair in Cancer Medicine
 Roswell Park Cancer Institute
Buffalo, NY, USA

- Kenneth C. Anderson, M.D.
Kraft Family Professor of Medicine
Harvard Medical School
 Dana-Farber Cancer Institute
Boston, USA
 
- Carlos L. Arteaga, M.D. 
Professor of medicine and cancer biology
Div. of Oncology Vanderbilt University School of Medicine
Director, VICC Breast Cancer Program
Nashville, Tennesse, USA
 
- Fernando Cabanillas, M.D.*
Clinical Professor of Medicine
University of Texas M. D. Anderson Cancer Center
Houston, Texas, USA

- Jorge Cortes, M.D. *
Associate Professor of Medicine
University of Texas M. D. Anderson Cancer Center
Houston, TX ,USA
 
- Hernán Cortés Funes,M.D.
Department of Medical Oncology
Hospital Universitario "12 de Octubre"
Madrid, Spain
 
- Guillermo García-Manero, M.D. *
Associate Professor of Medicine
Chief, Section of Myelodysplastic Syndromes
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Texas, USA
 
- Josep  LLovet, M.D.
Professor of Research, ICREA
BCLC Group, Liver Unit, IDIBAPS
CIBERehd, Hospital Clínic
Barcelona, Spain
Director, Mount Sinai Liver Cancer Research Program
Mount Sinai School of Medicine. New York
 
- Edith Perez,M.D.
Serene M. and Frances C. Durling Professor of Medicine
Deputy Director, Mayo Clinic Cancer Center
Mayo Clinic
Jacksonville, Florida, USA
 
- Roman Perez-Soler, M.D.
Chairman, Department of Oncology
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, NY, USA

- Antoni Ribas, M.D.
Associate Professor of Medicine and Surgery at UCLA
Director, Tumor Immunology Program Area
Jonsson Comprehensive Cancer Center (JCCC)
Director, Cell and Gene Therapy Manufacture Core Facility
Los Angeles, California 
 
- Joyce O'Shaughnessy M.D.
Co-Director of the Breast Cancer Research Program
Baylor-Charles A Sammons Cancer Center
US Oncology, Dallas, Texas, USA

- Josep Tabernero, M.D.
Chairman
Medical Oncology Department
Vall d’Hebron University Hospital
Barcelona, Spain

 *To be confirmed

• Programa preliminar
 
-PI3 kinase Inhibitors in Breast Cancer:
Carlos L. Arteaga, Nashville, USA
 
-Angiogenesis Inhibitors in Breast Cancer:
Hernán Cortés Funes, Madrid, Spain
 
-Current Treatment of HER2+ Disease Including Latest Combinations:
Edith Perez, Mayo Clinic, Jacksonville, USA
 
-PARP Inhibitors in Breast Cancer :
Joyce O'Shaughnessy, Texas, USA
 
-New Advances in the Treatment of Ovarian Cancer:
TBA
 -Advances in Frontline Treatment in Lung Cancer:
Román Pérez Soler, New York, USA
 
- Novel Treatments and Targets in Lung Cancer: :
Alex Adjei, Buffalo, NY, USA
 
-Use of Molecular Markers in Lung Cancer :
Román Pérez Soler, New York, USA

 -Leukemia:
Jorge Cortes, Houston,TX, USA*
 
-Multiple Myeloma:
Kenneth C. Anderson, Boston, USA
 
-Novel Targeted Therapy for Lymphoma:
Fernando Cabanillas, Houston, TX, USA*

-Implication of Biomarkers in the Algorithm of 1st Line Treatment in Advanced Colorectal Cancer :
Josep Tabernero, Barcelona,Spain

- Anti VEGF in GI Cancer:
TBA
 
- Targeted Therapies for Renal and Prostate Cancer:
TBA
 
-Hepatocellular Carcinoma :
Josep LLovet, Barcelona,Spain
 
-Promising Agents in Early Clinical Trials:
Alex Adjei, Buffalo, NY, USA

-Targeted Therapy for Melanoma:
Antoni Ribas, California, USA

Informes e Inscripción

E-mail:  secretariat@oncologyconferences.com.ar
Website: www.oncologyconferences.com.ar